Transcripts

Phibro Animal Health (PAHC) earnings call transcripts

Earnings call transcripts for Phibro Animal Health Corp., with a summary, the guidance given, and what analysts pressed on.

Open PAHC in Gloom →
  • Q4 2026 earnings call

    Management framed FY27 as a confident but prudent growth year, with Brazilian regulatory uncertainty excluded from the plan and cost savings still ramping.

    Date n/aPositive0.55
  • Q3 2026 earnings call

    Management framed the quarter as broad-based growth while emphasizing Brazil’s antimicrobial transition, sustainability expansion, and higher full-year guidance floors.

    Date n/aPositive0.65
  • Q2 2026 earnings call

    Management framed the quarter as evidence that MFA integration and commercial execution are working, while highlighting broad protein demand and an upcoming leadership transition.

    Date n/aConfident0.78